- Home
- LNTH vs UGI Comparison
LNTH vs UGI Comparison
Compare LNTH & UGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LNTH | UGI |
|---|---|---|
| Founded | 1956 | 1940 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Natural Gas Distribution |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 8.1B |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | LNTH | UGI |
|---|---|---|
| Price | $66.17 | $38.24 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 1 |
| Target Price | ★ $78.00 | $44.00 |
| AVG Volume (30 Days) | 1.2M | ★ 2.6M |
| Earning Date | 11-06-2025 | 02-04-2026 |
| Dividend Yield | N/A | ★ 3.94% |
| EPS Growth | N/A | ★ 147.20 |
| EPS | 2.39 | ★ 3.09 |
| Revenue | $1,525,933,000.00 | ★ $7,287,000,000.00 |
| Revenue This Year | $0.01 | $27.27 |
| Revenue Next Year | $1.24 | $2.85 |
| P/E Ratio | $27.55 | ★ $12.33 |
| Revenue Growth | ★ 1.95 | 1.07 |
| 52 Week Low | $47.25 | $26.80 |
| 52 Week High | $111.29 | $39.59 |
Technical Indicators
Market Signals| Indicator | LNTH | UGI |
|---|---|---|
| Relative Strength Index (RSI) | 67.34 | 62.22 |
| Support Level | $64.13 | $37.90 |
| Resistance Level | $67.01 | $38.51 |
| Average True Range (ATR) | 2.17 | 0.69 |
| MACD | 0.32 | -0.13 |
| Stochastic Oscillator | 84.68 | 46.32 |
Price Performance
Historical ComparisonAbout LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About UGI UGI Corporation
UGI Corp is an American holding company that, through its subsidiaries, is involved in the transport and marketing of energy and related services. Its segments include AmeriGas Propane, UGI International, Midstream & Marketing, and Utilities. The AmeriGas Propane segment consists of the propane distribution business. The UGI International segment consists of LPG distribution businesses. The Midstream & Marketing segment consists of energy-related businesses. The Utilities segment consists of the regulated natural gas and electric distribution. The company derives a majority of its revenue from the UGI International segment.